logo-loader

Braveheart Investment Group Pharm2Farm designs antiviral face mask to kill COVID-19

Published: 14:14 26 Oct 2020 GMT

Braveheart Investment Group PLC (LON:BRH) investee company Pharm2Farm's (P2F) Gareth Cave talks to Proactive London about their new antiviral face mask that can kill coronavirus (COVID-19).

Cave talks through the technology behind the mask, which is says is much stronger than the standard mask being used by the masses to defend themselves against the virus.

Cave demonstrates the textile coating which incorporates nanoparticles with long-lasting virucidal properties.

FTSE 100 fails to break 7,500 point ceiling - Market Report

Good morning from London where the FTSE 100 is up so far and hovering around the 7,450 level. It's been scudding along just below the 7,500 level for most of this week. Looking at some equities in particular, housebuilder Berkeley Group Holdings PLC (LSE:BKG) said this morning that it is...

on 8/9/23